Home › Tickers › REGN

Regeneron Pharmaceuticals, Inc. (REGN) — GAAP EPS actuals & earnings history

As-filed GAAP earnings, announcement timing (BMO/AMC), margins, and Form 4 insider transactions for Regeneron Pharmaceuticals, Inc. — every data point sourced from SEC EDGAR and auditable to the original filing.

Coverage for REGN

Aegwah tracks 61 quarters of as-filed GAAP EPS for Regeneron Pharmaceuticals, Inc., spanning 2011-03 to 2026-03. Every figure is traceable to the original SEC filing. Verify any number directly on SEC EDGAR.

What you get for REGN

• As-filed diluted & basic GAAP EPS (split-adjusted) for every reported quarter
• Revenue, net income, and gross margin where reported in XBRL
• Announcement timing — before-market (BMO) or after-market (AMC) from matched 8-K acceptance time
• Form 4 insider open-market buys & sells (Pro adds clusters & conviction scores)
• The SEC edgar_accession and filing_url on every EDGAR-sourced record

Access REGN data via API

The same membership unlocks a ZIP download and a Bearer-token REST API:

curl -H "Authorization: Bearer <your-key>" \
  https://api.aegwah.com/v1/actuals/REGN

Related: how this data is sourced & scored · per-ticker quality report · REGN filings on SEC EDGAR